Effect of Neurofeedback Training on Depression and Fatigue in Patients with Multiple Sclerosis

  • Azadeh Choobforoushzadeh
  • Hamid Taher Neshat-Doost
  • Hossien Molavi
  • Mohammad Reza Abedi
Article

Abstract

Depression and fatigue are common symptoms of multiple sclerosis (MS) and are the primary determinants of impaired quality of life in this demyelinating neurological disease. Untreated depression is associated with suicidal ideation, impaired cognitive function and poor adherence to immunomodulatory treatment. For these reasons, systematic screening and management of depressive symptoms and fatigue is recommended for all patients with MS. The objective of this study was to evaluate the effectiveness of neurofeedback in treating depression and fatigue in persons with MS. We conducted a randomized trial with 24 MS patients with primary fatigue and depression. Participants were randomized into two groups: neurofeedback training group (16 sessions of NFB) or treatment as usual. Participants were evaluated at 3 time points (baseline, end of the treatment, and 2-month follow-up) using the Fatigue Severity Scale and Depression subscale of the Hospital Anxiety and Depression Scale as outcome measures. A repeated measures analysis of variance was used to examine differences between the groups. NFB significantly reduced symptoms of depression and fatigue in patients with MS patients, compared to treatment as usual (p < .05), and these effects were maintained the 2-month follow-up (p < .05).

Keywords

Multiple sclerosis Fatigue Depression Neurofeedback Fatigue Severity Scale Hospital Anxiety and Depression Scale 

References

  1. Aikens, J. E., Fischer, J. S., Namey, M., & Rudick, R. A. (1997). A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis. Journal of Behavioral Medicine, 5, 433–445.CrossRefGoogle Scholar
  2. Aronson, K. (1996). Quality of life among persons with multiple sclerosis and their caregivers. Neurology, 48, 74–80.CrossRefGoogle Scholar
  3. Baehr, E., Miller, L., Rosenfeld, J., & Baehr, R. (2004). Changes in frontal brain asymmetry associated with premenstrual dysphoric disorder: A single case study. Journal of Neurofeedback, 8(1), 29–42.Google Scholar
  4. Baehr, E., Rosenfeld, J., & Baehr, R. (1997). The clinical use of an alpha asymmetry protocol in the neurofeedback treatment of depression: Two case studies. Journal of Neurofeedback, 2(3), 10–23.Google Scholar
  5. Baehr, E., Rosenfeld, J., & Baehr, R. (2001). The clinical use of an alpha asymmetry protocol in the treatment of mood disorders: Follow-up study one to five years post therapy. Journal of Neurofeedback, 4(4), 11–18.Google Scholar
  6. Baehr, E., Rosenfeld, J. P., Baehr, R., & Earnest, C. (1999). Clinical use of an alpha asymmetry neurofeedback protocol in the treatment of mood disorders. In J. R. Evans & A. Abarbanel (Eds.), Introduction to quantitative EEG and neurofeedback (pp. 181–200). New York: Academic Press.CrossRefGoogle Scholar
  7. Bakshi, R., Shaikh, Z. A., Miletich, R. S., Czarnecki, D., Dmochowski, J., Henschel, K., et al. (2000). Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Multiple Sclerosis, 6, 181–185.CrossRefPubMedGoogle Scholar
  8. Bergamaschi, R., Romani, A., Versino, M., Poli, R., & Cosi, V. (1997). Clinical aspects of fatigue in multiple sclerosis. Functional Neurology, 12, 247–251.PubMedGoogle Scholar
  9. Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale: An updated review. Journal of Psychiatric Research, 52, 69–77.Google Scholar
  10. Braley, T. J., & Chervin, R. D. (2010). Fatigue in multiple sclerosis: Mechanisms, evaluation, and treatment. Sleep, 33, 1061–1067.PubMedCentralPubMedGoogle Scholar
  11. Clark, C. M., Fleming, J. A., Li, D., Oger, J., Klonoff, H., & Paty, D. (1992). Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Archive of Neurology, 49, 641–643.CrossRefGoogle Scholar
  12. Colosimo, C., Millefiorini, E., Grasso, M. G., Vinci, F., Fiorelli, M., Koudriavtseva, T., et al. (1995). Fatigue in MS is associated with specific clinical features. Acta Neurologica Scandinavica, 92, 353–355.CrossRefPubMedGoogle Scholar
  13. Comi, G., Leocani, L., Rossi, P., & Colombo, B. (2001). Physiopathology and treatment of fatigue in multiple sclerosis. Journal of Neurology, 248(174), 9.Google Scholar
  14. Davidson, R. J. (1992). Emotion and affective style: Hemispheric substrates. Psychological Science, 3, 39–43.CrossRefGoogle Scholar
  15. Davidson, R. J. (1995). Cerebral asymmetry, emotion and affective style. In R. J. Davidson & K. Hugdahl (Eds.), Brain asymmetry (pp. 361–387). Boston: MIT Press.Google Scholar
  16. Davidson, R. J. (1998a). Affective style and affective disorders: Perspectives from affective neuroscience. Cognition and Emotion, 12, 307–330.CrossRefGoogle Scholar
  17. Davidson, R. J. (1998b). Anterior electrophysiological asymmetries, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology, 35, 607–614.CrossRefPubMedGoogle Scholar
  18. Dawson, G., Klinger, L. G., Panagiotides, H., Hill, D., & Spieker, S. (1992a). Frontal lobe activity and affective behavior of infants of mothers with depressed symptoms. Child Development, 63, 725–737.CrossRefPubMedGoogle Scholar
  19. Dawson, G., Klinger, L. G., Panagiotides, H., Spieker, S., & Frey, K. (1992b). Infants of mothers with depressed symptoms: electroencephalographic and behavioral findings related to attachment status. Development and Psychopathology, 4, 67–80.CrossRefGoogle Scholar
  20. Dursun, E., Dursun, N., & Alican, D. (2004). Effects of biofeedback treatment on gait in children with cerebral palsy. Disability and Rehabilitation, 26, 116–120.CrossRefPubMedGoogle Scholar
  21. Egner, T., Strawson, E., & Gruzelier, J. H. (2002). EEG signature and phenomenology of alpha-theta neurofeedback training versus mock feedback. Applied Psychophysiology and Biofeedback, 27, 261–270.Google Scholar
  22. Fassbender, K., Schmidt, R., Mobner, R., Kischka, U., Kuhnen, J., Schwartz, A., et al. (1998). Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis. Archive of Neurology, 55, 66–72.CrossRefGoogle Scholar
  23. Feinstein, A. (2002). An examination of suicidal intent in patients with multiple sclerosis. Neurology, 59, 674–678.CrossRefPubMedGoogle Scholar
  24. Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994). The impact of fatigue on patients with multiple sclerosis. Canadian Journal of Neurological Sciences, 21, 9–14.PubMedGoogle Scholar
  25. Flachenecker, P., Kumpfel, T., Kallmann, B., Gottschalk, M., Grauer, O., Rieckmann, P., et al. (2002). Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Multiple Sclerosis, 8, 523–526.CrossRefPubMedGoogle Scholar
  26. Foong, J., & Ron, M. A. (2003). Neuropsychiatry: cognition and mood disorders. In W. I. McDonald & J. H. Noseworthy (Eds.), Multiple sclerosis—2 (pp. 115–124). Philadelphia: Butterworth-Heinemann Publishers.Google Scholar
  27. Ford, H., Trigwell, P., & Johnson, M. (1998). The nature of fatigue in multiple sclerosis. Journal of Psychosomatic Research, 45, 33–38.CrossRefPubMedGoogle Scholar
  28. Freal, J., Kraft, G. H., & Coryell, J. (1984). Symptomatic fatigue in multiple sclerosis. Archive of Neurology, 53, 185–188.Google Scholar
  29. Goodkine, D. (1992). The natural history of multiple sclerosis. New York: Springer-Verlag.CrossRefGoogle Scholar
  30. Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Science, 256, 34–38.CrossRefGoogle Scholar
  31. Hammond, D. C. (2000). Neurofeedback treatment of depression with the Roshi. Journal of Neurotherapy, 4(2), 45–56.CrossRefGoogle Scholar
  32. Hammond, D. C. (2003). QEEG-guided neurofeedback in the treatment of obsessive compulsive disorder. Journal of Neurotherapy, 7(2), 25–52.CrossRefGoogle Scholar
  33. Hammond, D. (2005a). Neurofeedback treatment of depression and anxiety. Journal of Adult Development, 12(2/3), 131–1377.CrossRefGoogle Scholar
  34. Hammond, D. (2005b). Neurofeedback with anxiety and affective disorders. Child and Adolescent Psychiatric Clinics of North America, 14, 105–123.CrossRefPubMedGoogle Scholar
  35. Hanslmayr, S., Sauseng, P., Doppelmayr, M., Schabus, M., & Klimesch, W. (2005). Increasing individual upper alpha power by Neurofeedback improves cognitive performance in human subjects. Applied Psychophysiology and Biofeedback, 30(1), 1–10.CrossRefPubMedGoogle Scholar
  36. Hauser, S. L., & Goodkin, D. E. (2001). MS & demyelinating disease. In T. R. Harrison, E. Brown, A. S. Fauci, D. L. Kasper, S. L. Hauser, & D. L. Longo (Eds.), Harrison’s principles of internal medicine (15th ed., Vol. 4, pp. 2452–2460). New York: McGraw- Hill.Google Scholar
  37. Hendin, H. (1999). Suicide, assisted suicide, and medical illness. Journal of Clinical Psychiatry, 60, 46–50.PubMedGoogle Scholar
  38. Henriques, J. B., & Davidson, R. J. (1991). Left frontal hypoactivation in depression. Journal of Abnormal Psychology, 100, 535–545.CrossRefPubMedGoogle Scholar
  39. Heron, R., McCann, G., & O’Leary, C. P. (1999). The influence of multiple sclerosis on fatigue levels and physical activity levels. Multiple Sclerosis, 5, 37.Google Scholar
  40. How long do the effects of neurofeedback training last?(2010). http://www.aboutneurofeedback.com/.
  41. Iwasaki, Y., Iwamoto, K., Igarashi, O., Kiyozuka, T., Aoyagi, J., Hirano, K., et al. (2005). Depression in multiple sclerosis. Acta Neurologica Scandinavica, 111, 209.CrossRefPubMedGoogle Scholar
  42. Janardhan, V., & Bakshi, R. (2002). Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. Journal of eurological Science, 205, 51–58.CrossRefGoogle Scholar
  43. Kaminska, M., Kimoff, R. J., Schwartzman, K., & Trojan, D. A. (2011). Sleep disorders and fatigue in multiple sclerosis: Evidence for association and interaction. Journal of Neurological Science, 302, 7–13.CrossRefGoogle Scholar
  44. Kano, K., Nakamura, M., Matsuoka, T., Iida, H., & Nakajima, T. (1992). The topographical features of EEGs in patients with affective disorders. Electroencephalography Clinical Neurophysiology, 83, 124–129.CrossRefPubMedGoogle Scholar
  45. Kayıran, S., Dursun, E., Dursun, N., Ermutlu, N., & Karamursel, S. (2010). Neurofeedback intervention in fibromyalgia syndrome: A randomized, controlled, rater blind clinical trial. Applied Psychophysiology and Biofeedback, 35, 293–302.CrossRefPubMedGoogle Scholar
  46. Kroencke, D. C., Lynch, S. G., & Denney, D. R. (2000). Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Multiple Sclerosis, 6, 131–136.CrossRefPubMedGoogle Scholar
  47. Krupp, L. B., Alvarez, L., LaRocca, N., & Scheinberg, L. (1988). Fatigue in multiple sclerosis. Archive of Neurology, 45, 435–437.CrossRefGoogle Scholar
  48. Krupp, L. B., LaRocca, N., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archive of Neurology, 46(10), 1121–1123.CrossRefGoogle Scholar
  49. Lubar, J. F. (1997). Neocortical dynamics: Implications for understanding the role of neurofeedback and related techniques for the enhancement of attention. Applied Psychophysiology and Biofeedback, 22, 111–126.CrossRefPubMedGoogle Scholar
  50. Marrie, R. A., Horowitz, R., Cutter, G., Tyry, T., Campagnolo, D., & Vollmer, T. (2009). The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed and undertreated. Multiple Sclerosis, 15, 385–392.CrossRefPubMedGoogle Scholar
  51. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50, 121–127.CrossRefPubMedGoogle Scholar
  52. McGuigan, C., & Hutchinson, M. (2006). Unrecognised symptoms of depression in a community-based population with multiple sclerosis. Journal of Neurology, 253, 219–223.CrossRefPubMedGoogle Scholar
  53. Minden, S. L., Orav, J., & Reich, P. (1987). Depression in multiple sclerosis. General Hospital Psychiatry, 9, 426–434.Google Scholar
  54. Mohr, D. C., Hart, S. L., Fonareva, I., & Tasch, E. S. (2006). Treatment of depression for patients with multiple sclerosis in neurology clinics. Multiple Sclerosis, 12, 204–208.CrossRefPubMedGoogle Scholar
  55. Muller, H. H., Donaldson, C. C. S., Nelson, D. V., & Layman, M. (2001). Treatment of fibromyalgia incorporating EEG-driven stimulation: a clinical study. Journal of Clinical Psychology, 57(7), 925–933.Google Scholar
  56. Multiple Sclerosis Council for Clinical Practice Guidelines. (1998). Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis. Multiple Sclerosis Council for Clinical Practice Guidelines.Google Scholar
  57. Murray, T. J. (1985). Amantadine therapy for fatigue in multiple sclerosis. Canadian Journal of Neurological Sciences, 12, 251–254.PubMedGoogle Scholar
  58. Neurofeedback and multiple sclerosis.(2009).http://www.sinhaclinic.com/ .
  59. Nocentini, U. (2006). Clinical assessment for depression. Neurological Sciences, 27, 341–343.CrossRefGoogle Scholar
  60. Patten, S., Metz, L. M., & Reimer, M. A. (2000). Biopsychosocial correlates of life time major depression in a multiple sclerosis population. Multiple Sclerosis, 6, 115–120.CrossRefPubMedGoogle Scholar
  61. Provinciali, L., Ceravolo, M. G., Bartolini, M., Logullo, F., & Danni, M. (1999). A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurologica Scandinavica, 100, 156–162.CrossRefPubMedGoogle Scholar
  62. Putman, J. A. (2001). EEG biofeedback on a female patient stroke patient with depression: a case study. Journal of Neurotherapy, 5(3), 27–38.CrossRefGoogle Scholar
  63. Rickards, H. (2005). Depression in neurological disorders: Parkinson’s disease, multiple sclerosis and stroke. Journal of Neurology, Neurosurgery and Psychiatry, 76, 48–52.CrossRefGoogle Scholar
  64. Ros, T., Munneke, M. A. M., Ruge, D., Gruzelier, J. H., & Rothwell, J. C. (2010). Endogenous control of waking brain rhythms induces neuroplasticity in humans. European Journal of Neuroscience, 31, 770–778.CrossRefPubMedGoogle Scholar
  65. Rosenfeld, J. P., Cha, G., Blair, T., & Gotlib, I. (1995). Operant biofeedback control of left-right frontal alpha power differences. Biofeedback Self Regulation, 20, 241–258.CrossRefPubMedGoogle Scholar
  66. Salehpoor, G. H., Rezaei, S., & Hossininezhad, M. (2013). Psychometric properties of fatigue severity scale in patients with multiple sclerosis. Journal of Kerman University of Medical Sciences, 20(3), 263–278.Google Scholar
  67. Sevène, A., Akrour, B., Galimard-Maisonneuve, E., Kutneh, M., Royer, P., & Sevène, M. (2009). Multiple sclerosis and sexuality: A complex model. Sexologies, 18, 86–90.CrossRefGoogle Scholar
  68. Sharrack, B., & Hughes, R. A. (1996). Clinical scales for multiple sclerosis. Journal of Neurological Science, 135, 1–9.CrossRefGoogle Scholar
  69. Siegert, R., & Abernethy, D. (2006). Depression in multiple sclerosis: A review. Journal of Neurology Neurosurgery Psychiatry, 76, 469–475.CrossRefGoogle Scholar
  70. Sollom, A. C., & Kneebone, I. (2007). Treatment of depression in people who have multiple sclerosis. Multiple Sclerosis, 13, 632–635.CrossRefPubMedGoogle Scholar
  71. Stein, M. B., Cox, B. J., Afifi, T. O., Belik, S., & Sareen, J. (2006). Does comorbid illness magnify the impact of chronic physical illness? A population based perspective. Psychological Medicine, 36, 587–596.CrossRefPubMedGoogle Scholar
  72. Stenager, E. N., & Stenager, E. (2000). Physical illness and suicidal behavior. In K. Hawton & K. van Heeringen (Eds.), The international handbook of suicide and attempted suicide. New York: Wiley.Google Scholar
  73. Sterman, M. B. (1999). Atlas of topometric clinical displays: Functional interpretations and neurofeedback strategies. Los Angeles: Sterman-Kaiser Imaging Laboratory.Google Scholar
  74. Sterman, M. B., & Kaiser, D. (2001). Comodulation: A new QEEG analysis metric for assessment of structural and functional disorders of the central nervous system. Journal of Neurotherapy, 4(3), 73–83.CrossRefGoogle Scholar
  75. Vanathy, S., Sharma, P. S. V. N., & Kumar, K. B. (1998). The efficacy of alpha and theta neurofeedback training in treatment of generalized anxiety disorder. Indian Journal of Clinical Psychology, 25(2), 136–143.Google Scholar
  76. Vernon, D., Egner, T., Cooper, N., Compton, T., Neilands, C., Sheri, A., et al. (2003). The effect of training distinct neurofeedback protocols on aspects of cognitive performance. International Journal of Psychophysiology, 47(1), 75–85.CrossRefPubMedGoogle Scholar
  77. Walker, J. (2007). Current status of QEEG and neurofeedback in the treatment of clinical depression. In J. R. Evans (Ed.), Handbook of neurofeedback: Dynamic and clinical applications (pp. 341–352). New York: Haworth Medical Press.CrossRefGoogle Scholar
  78. Williams, R. M., Turner, A. P., Hatzakis, M., Bowen, J. D., Rodriquez, A. A., & Haselkorn, J. K. (2005). Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology, 64, 75–80.CrossRefPubMedGoogle Scholar
  79. Wilson, V. E., Peper, E., & Moss, D. (2006). Professional issue “The mind room’’ in Italian soccer training: the use of biofeedback and neurofeedback for optimum performance. Biofeedback, 34, 79–810.Google Scholar
  80. Yucha, C., & Gilbert, C. (2004). Evidence-based practice in biofeedback and neurofeedback. Wheat Ridge CO: Association for Applied Psychophysiology and Biofeedback.Google Scholar
  81. Yucha, C., & Montgomery, D. (2008). Evidence-based practice in biofeedback and neurofeedback. Wheat Ridge: Association for Applied Psychophysiology and Biofeedback.Google Scholar
  82. Ziemssen, T. (2009). Multiple sclerosis beyond EDSS: depression and fatigue. Journal of the Neurological Science, 277, 37–41.CrossRefGoogle Scholar
  83. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatry Scandinavia, 67(6), 361–370.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Azadeh Choobforoushzadeh
    • 1
  • Hamid Taher Neshat-Doost
    • 1
  • Hossien Molavi
    • 1
  • Mohammad Reza Abedi
    • 2
  1. 1.Department of PsychologyUniversity of IsfahanIsfahanIran
  2. 2.Department of CounselingUniversity of IsfahanIsfahanIran

Personalised recommendations